UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): ~~March~~April 59, 2026

Invivyd, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware

001-40703

85-1403134

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

209 Church Street

New Haven, CT

06510

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code: (781) 819-0080

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		~~TradingSymbol~~Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.0001 per share		IVVD		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 28.~~02.~~01 ~~Results~~Other ~~of Operations and Financial Condition~~Events.

On ~~March~~April 59, 2026, Invivyd, Inc. (the “Company”) issued a press release ~~announcing~~entitled ~~its~~“Invivyd ~~financial~~Announces ~~results~~REVOLUTION ~~for~~Program ~~the~~Progress ~~fourth~~and ~~quarter~~Advancement of Novel, Potential First- and ~~year~~Best-in-Class ~~ended~~Measles ~~December 31,~~Monoclonal ~~2025,~~Antibody Candidate VMS063 for Treatment and ~~recent~~Prevention ~~business~~of ~~highlights~~Measles.” A copy of the press release is ~~furnished~~filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 28.0201.

~~The~~On ~~information~~April 9, ~~furnished pursuant to this Item 2.02~~2026, ~~including~~the ~~Exhibit~~Company ~~99.1,~~posted ~~shall~~an ~~not~~updated becorporate ~~deemed~~presentation toon beits ~~“filed”~~website ~~for~~at ~~purposes~~www.invivyd.com. ofA ~~Section 18~~copy of the ~~Securities~~presentation ~~Exchange~~is ~~Act~~filed ~~of 1934,~~ as ~~amended~~Exhibit ~~(the~~99.2 ~~“Exchange Act”), or otherwise subject~~ to ~~the~~this ~~liabilities~~Current ofReport ~~that~~on ~~Section,~~Form ~~nor~~8-K ~~shall~~and itis ~~be deemed to be~~ incorporated by reference into ~~any~~this ofItem the Company’s filings with the Securities and Exchange Commission under the Exchange Act or the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such a filing, except as expressly set forth by specific reference in such a filing8.01.

Item 89.01. ~~Other~~Financial ~~Events~~Statements and Exhibits.

On March 5, 2026, the Company posted an updated corporate presentation on its website at www.invivyd.com. A copy of the presentation is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

ExhibitNo.		Description
99.1		Press Release, dated ~~March~~April 59, 2026
99.2		Corporate Presentation, dated ~~March~~April 59, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INVIVYD, INC.

Date: March 5, 2026

/s/ Jill Andersen

Date: April 9, 2026

/s/ Jill Andersen

Jill Andersen

Chief Legal Officer and Corporate Secretary

Filing Compare · Invivyd, Inc.